Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	147,996	293,004	172,366	120,256	157,436	126,468
Market Cap Growth	-47.23%	69.99%	43.33%	-23.61%	24.49%	394.20%
Enterprise Value	149,868	287,341	165,176	117,048	156,449	127,128
Last Close Price	386.55	1159.80	676.60	472.70	608.03	483.61
PE Ratio	83.62	109.38	57.40	29.24	34.69	34.90
PS Ratio	12.22	24.47	16.40	8.97	11.93	12.53
PB Ratio	3.77	15.92	8.40	6.93	10.31	10.71
P/TBV Ratio	6.08	29.97	8.67	7.19	10.32	10.73
P/FCF Ratio	108.35	221.22	51.78	70.21	61.79	46.55
P/OCF Ratio	71.25	101.68	44.80	26.30	47.71	33.06
EV/Sales Ratio	12.38	23.99	15.71	8.73	11.85	12.59
EV/EBITDA Ratio	48.33	70.85	40.39	20.44	27.00	28.85
EV/EBIT Ratio	71.20	87.58	46.61	22.25	28.89	31.02
EV/FCF Ratio	109.72	216.94	49.62	68.34	61.40	46.79
Debt / Equity Ratio	0.12	0.15	0.03	0.04	0.06	0.12
Debt / EBITDA Ratio	1.45	0.69	0.16	0.12	0.17	0.32
Debt / FCF Ratio	3.30	2.11	0.20	0.41	0.38	0.53
Asset Turnover	0.30	0.45	0.50	0.71	0.80	0.76
Inventory Turnover	0.84	1.85	1.32	1.87	2.24	2.19
Quick Ratio	1.59	1.78	8.61	4.17	3.85	1.56
Current Ratio	2.92	2.43	10.68	6.37	5.36	2.57
Return on Equity (ROE)	5.51%	13.61%	15.86%	25.21%	33.52%	35.78%
Return on Assets (ROA)	3.26%	7.76%	10.50%	17.33%	20.49%	19.35%
Return on Invested Capital (ROIC)	5.57%	16.10%	20.05%	31.95%	32.95%	29.89%
Return on Capital Employed (ROCE)	4.30%	12.30%	16.60%	29.10%	33.40%	32.70%
Earnings Yield	1.20%	0.91%	1.74%	3.42%	2.88%	2.86%
FCF Yield	0.92%	0.45%	1.93%	1.42%	1.62%	2.15%
Dividend Yield	-	-	-	-	0.33%	0.41%
Payout Ratio	-	-	-	49.52%	11.22%	7.03%
Buyback Yield / Dilution	-0.56%	-0.49%	-	-	-	0.00%
Total Shareholder Return	-0.56%	-0.49%	-	-	0.33%	0.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.